HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 614 filers reported holding HORIZON THERAPEUTICS PUB L in Q1 2022. The put-call ratio across all filers is 0.63 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $583,342,877 | +3.3% | 5,042,293 | -8.2% | 0.06% | +4.9% |
Q2 2023 | $564,774,035 | -5.7% | 5,491,240 | +0.1% | 0.06% | -16.4% |
Q1 2023 | $598,828,590 | +46679.0% | 5,486,771 | -51.2% | 0.07% | -56.8% |
Q4 2022 | $1,280,123 | -99.7% | 11,248,889 | +65.7% | 0.17% | +181.7% |
Q3 2022 | $420,088,000 | -20.8% | 6,787,642 | +2.0% | 0.06% | -18.9% |
Q2 2022 | $530,605,000 | -17.6% | 6,652,529 | +8.7% | 0.07% | -5.1% |
Q1 2022 | $643,725,000 | -1.8% | 6,118,479 | +0.6% | 0.08% | +2.6% |
Q4 2021 | $655,282,000 | +2.9% | 6,080,954 | +4.6% | 0.08% | -3.8% |
Q3 2021 | $636,889,000 | +13.1% | 5,814,230 | -3.3% | 0.08% | +17.9% |
Q2 2021 | $562,901,000 | +8.5% | 6,011,329 | +6.7% | 0.07% | -2.9% |
Q1 2021 | $518,662,000 | +20.0% | 5,635,181 | -4.6% | 0.07% | +9.5% |
Q4 2020 | $432,166,000 | +7.1% | 5,907,934 | +14.5% | 0.06% | -7.4% |
Q3 2020 | $403,353,000 | +54.4% | 5,160,610 | +9.8% | 0.07% | +36.0% |
Q2 2020 | $261,216,000 | +113.3% | 4,699,798 | +13.7% | 0.05% | +72.4% |
Q1 2020 | $122,451,000 | -9.7% | 4,134,098 | +10.4% | 0.03% | +16.0% |
Q4 2019 | $135,548,000 | +1.2% | 3,744,444 | -23.9% | 0.02% | -7.4% |
Q3 2019 | $134,003,000 | +9.4% | 4,921,143 | -3.3% | 0.03% | +12.5% |
Q2 2019 | $122,480,000 | – | 5,090,627 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |